Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / KALA - Kala Pharmaceuticals: Rating Buy Ahead Of STRIDE 3 Data This Quarter


KALA - Kala Pharmaceuticals: Rating Buy Ahead Of STRIDE 3 Data This Quarter

Kala Pharmaceuticals (KALA) is based in the Boston area, Massachusetts, and is focused on developing topical treatments for eye diseases using its proprietary MPP (Mucus Penetrating Particles) technology. Topically administered eye medications are usually trapped by the mucus in the tear film that covers the cornea, thus limiting the drug's access to the eye tissues. The MPP technology allows the drug to penetrate the mucus in the tear film effectively, thus creating a potential for lower dose or less frequent dosing. The technology has origins in MIT Labs.

The first product candidate from

Read more ...

Stock Information

Company Name: Kala Pharmaceuticals Inc.
Stock Symbol: KALA
Market: NASDAQ
Website: kalarx.com

Menu

KALA KALA Quote KALA Short KALA News KALA Articles KALA Message Board
Get KALA Alerts

News, Short Squeeze, Breakout and More Instantly...